Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Jarabek

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Toxicology Letters|September 1, 1995
The application of dosimetry models to identify key processes and parameters for default dose-response assessment approachesA M Jarabek
Toxicology Letters|December 1, 1995
Understanding mechanisms of inhaled toxicants: implications for replacing default factors with chemical-specific dataM S Bogdanffy, A M Jarabek
Inhalation Toxicology|April 11, 2001
Nasal tissue dosimetry-issues and approaches for "Category 1" gases: a report on a meeting held in Research Triangle Park, NC, February 11-12, 1998M E Andersen, A M Jarabek
Toxicology and Industrial Health|October 1, 1990
The U.S. Environmental Protection Agency's risk assessment guidelinesA M Jarabek, W H Farland
Toxicology and Industrial Health|October 1, 1990
Research on risk assessment and risk management: future directionsL D Grant, A M Jarabek
Experimental Pathology|January 1, 1989
Estimating equivalent human concentrations of no observed adverse effect levels: a comparison of several methodsJ H Overton, A M Jarabek
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1991
Sensitivity analysis for physiologically based pharmacokinetic modelsD M Hetrick, A M Jarabek, C C Travis
Inhalation Toxicology|April 11, 2001
Mass transport analysis: inhalation rfc methods framework for interspecies dosimetric adjustmentL M Hanna, S R Lou, S Su, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 2, 1998
The EPA health risk assessment of methylcyclopentadienyl manganese tricarbonyl (MMT)J M Davis, A M Jarabek, D T Mage, et al.
Environmental Research|March 27, 1999
Inhalation health risk assessment of MMTJ M Davis, A M Jarabek, D T Mage, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Toxicology Letters|September 1, 1995
The application of dosimetry models to identify key processes and parameters for default dose-response assessment approachesA M Jarabek
Toxicology Letters|December 1, 1995
Understanding mechanisms of inhaled toxicants: implications for replacing default factors with chemical-specific dataM S Bogdanffy, A M Jarabek
Inhalation Toxicology|April 11, 2001
Nasal tissue dosimetry-issues and approaches for "Category 1" gases: a report on a meeting held in Research Triangle Park, NC, February 11-12, 1998M E Andersen, A M Jarabek
Toxicology and Industrial Health|October 1, 1990
The U.S. Environmental Protection Agency's risk assessment guidelinesA M Jarabek, W H Farland
Toxicology and Industrial Health|October 1, 1990
Research on risk assessment and risk management: future directionsL D Grant, A M Jarabek
Experimental Pathology|January 1, 1989
Estimating equivalent human concentrations of no observed adverse effect levels: a comparison of several methodsJ H Overton, A M Jarabek
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1991
Sensitivity analysis for physiologically based pharmacokinetic modelsD M Hetrick, A M Jarabek, C C Travis
Inhalation Toxicology|April 11, 2001
Mass transport analysis: inhalation rfc methods framework for interspecies dosimetric adjustmentL M Hanna, S R Lou, S Su, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 2, 1998
The EPA health risk assessment of methylcyclopentadienyl manganese tricarbonyl (MMT)J M Davis, A M Jarabek, D T Mage, et al.
Environmental Research|March 27, 1999
Inhalation health risk assessment of MMTJ M Davis, A M Jarabek, D T Mage, et al.
Pageof 2